BAFNA PHARMACEUTICALS
Back to Balance Sheet
|
BAFNA PHARMACEUTICALS Last 5 Year Sundry Debtors History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹44 Cr | ₹40 Cr | ₹45 Cr | ₹41 Cr | ₹15 Cr |
What is the latest Sundry Debtors ratio of BAFNA PHARMACEUTICALS ?
| Year | Sundry Debtors |
|---|---|
| Mar2026 | ₹44 Cr |
| Mar2025 | ₹40 Cr |
| Mar2024 | ₹45 Cr |
| Mar2023 | ₹41 Cr |
| Mar2022 | ₹15 Cr |
How is Sundry Debtors of BAFNA PHARMACEUTICALS Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2026 | ₹44 Cr | 9.35 | |
| Mar2025 | ₹40 Cr | -11.50 | |
| Mar2024 | ₹45 Cr | 10.32 | |
| Mar2023 | ₹41 Cr | 178.41 | |
| Mar2022 | ₹15 Cr | - | |
Compare Sundry Debtors of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹912.5 Cr | 8.2% | 22.2% | 260.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,280.0 Cr | -2.4% | -6.2% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,737.0 Cr | -3.3% | 1.4% | 57.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,129.0 Cr | -4.5% | -4% | 35.9% | Stock Analytics | |
| CIPLA | ₹108,808.0 Cr | -3.6% | -5% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,170.0 Cr | -0.2% | 2.5% | -3% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | 8.2% |
22.2% |
260.9% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses